Stifel maintains Hold on DXC Technology stock amid unit sale reports
Stifel reiterated a Hold rating and $10.50 price target on DXC Technology (NYSE:DXC) amid reports of potential insurance unit sale to Eldridge for $2.4B. DXC's insurance unit generated $1.3B in LTM revenue. DXC's stock trades at $14.26, with a P/E ratio of 20.18. The company reported mixed Q1 2027 results, missing EPS estimates but beating revenue forecasts. TD Cowen raised its price target to $12.00, maintaining a Hold rating.
How this was made
The 30-second read
Why it matters
The disclosed sale talks provide fresh material that could shift analyst expectations and influence short‑term price action.
Market read
Primary relevance to DXC stock; secondary relevance to the broader IT services sector.
What to watch
Potential regulatory approvals and integration risks for the buyer may delay or reduce the transaction value.
Background
DXC Technology, a large IT services firm, has been under pressure to improve margins; the insurance unit accounts for a modest share of earnings.
Ticker impact
DXC Technology is in late‑stage talks to sell its insurance unit for $2.4 billion, a new deal disclosed in this article.
likely modest downside as investors price in the sale and valuation uncertainty
The announced $2.4 bn sale represents ~10% of DXC's EBITDA and 14% of operating income, a material but not transformative transaction.
Market effects
May signal consolidation in IT services insurance niche, prompting peers to reassess similar units.
US IT services sector could see slight re‑rating as analysts adjust expectations for DXC.
Limited to DXC and its immediate competitors; no broad market impact.
Counterpoint
The sale could unlock value if proceeds are used for strategic acquisitions, potentially supporting upside.
Key entities
- CompanyDXC Technology
US‑listed IT services provider (ticker DXC).
- Private EquityEldridge
Potential buyer of DXC's insurance unit.
